Willis H Navarro

Summary

Affiliation: Genentech Inc
Country: USA

Publications

  1. ncbi AIDS-related lymphoproliferative disease
    Willis H Navarro
    Division of Hematology Oncology, University of California, San Francisco, 400 Parnassus Ave, Rm A502, San Francisco, CA 94143, USA
    Blood 107:13-20. 2006
  2. ncbi Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation
    Willis H Navarro
    University of California, San Francisco, San Francisco, California 94080 4990, and University Hospitals of Cleveland, OH, USA
    Biol Blood Marrow Transplant 12:541-51. 2006
  3. ncbi Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant
    Sonali M Smith
    Department of Medicine, The University of Chicago, Chicago, Illinois 60637, USA
    Biol Blood Marrow Transplant 14:904-12. 2008
  4. ncbi Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minorities
    Christopher J Schwake
    Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
    Biol Blood Marrow Transplant 11:988-98. 2005

Detail Information

Publications4

  1. ncbi AIDS-related lymphoproliferative disease
    Willis H Navarro
    Division of Hematology Oncology, University of California, San Francisco, 400 Parnassus Ave, Rm A502, San Francisco, CA 94143, USA
    Blood 107:13-20. 2006
    ..Significant progress has been made in the understanding and management of ARL but outcomes still remain inferior compared to those achieved in HIV- individuals...
  2. ncbi Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation
    Willis H Navarro
    University of California, San Francisco, San Francisco, California 94080 4990, and University Hospitals of Cleveland, OH, USA
    Biol Blood Marrow Transplant 12:541-51. 2006
    ....
  3. ncbi Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplant
    Sonali M Smith
    Department of Medicine, The University of Chicago, Chicago, Illinois 60637, USA
    Biol Blood Marrow Transplant 14:904-12. 2008
    ..HCT2 should be considered for patients with relapsed HL or NHL after HCT1 without alternative allogeneic stem cell transplant options...
  4. ncbi Differences in characteristics of US hematopoietic stem cell transplantation centers by proportion of racial or ethnic minorities
    Christopher J Schwake
    Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
    Biol Blood Marrow Transplant 11:988-98. 2005
    ..Our results suggest that the inferior survival reported in ethnic minorities after HSCT may not be readily explained by center effects...